How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.
441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 1 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 2 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| JWY · Manual Antimicrobial Susceptibility Test Systems | 441 | 78 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| MTS Ampicillin-Sulbactam 0.016/0.008 - 256/128 µg/mLK192345 · JWY | Liofilchem s.r.l. | 510(k) | Oct 31, 2019FDA decision date |
| Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Imipenem-Relebactam in the dilution range of 0.03/4-256/4 ug/mLK192250 · JWY | Thermo Fisher Scientific | 510(k) | Oct 16, 2019FDA decision date |
| ETEST Eravacycline (ERV) (0.002 32 µg/mL)K192050 · JWY | Biomerieux S.A. | 510(k) | Sep 27, 2019FDA decision date |
| MTS Imipenem 0.016-256 µg/mLK191908 · JWY | Liofilchem s.r.l. | 510(k) | Sep 4, 2019FDA decision date |
| MTS Imipenem-relebactam 0.002/4-32/4 µg/mLK191809 · JWY | Liofilchem s.r.l. | 510(k) | Aug 23, 2019FDA decision date |
| ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)K191953 · JWY | Biomerieux S.A. | 510(k) | Aug 22, 2019FDA decision date |
| MTS Doxycycline 0.016 - 256 µg/mLK190914 · JWY | Liofilchem s.r.l. | 510(k) | May 29, 2019FDA decision date |
| ETEST Piperacillin/Tazobactam (P/T) (0.016/4-256/4 ug/mL)K190154 · JWY | Biomerieux S.A. | 510(k) | May 1, 2019FDA decision date |
| MicroScan Dried Gram Negative MIC/Combo Panels with Eravacycline (ERV) (0.016-32 ug/mL)K190109 · JWY | Beckman Coulter, Inc. | 510(k) | Apr 18, 2019FDA decision date |
| MTS Gentamicin 0.016 - 256 µg/mLK190252 · JWY | Liofilchem s.r.l. | 510(k) | Mar 22, 2019FDA decision date |
| MTS Ciprofloxacin 0.002 - 32 µg/mLK183527 · JWY | Liofilchem s.r.l. | 510(k) | Mar 19, 2019FDA decision date |
| Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Omadacycline in the dilution r…K183324 · JWY | Thermo Fisher Scientific | 510(k) | Feb 15, 2019FDA decision date |
| ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL)K183031 · JWY | Biomerieux S.A. | 510(k) | Jan 11, 2019FDA decision date |
| MTS Tetracycline 0.016 - 256 ug/mLK183140 · JWY | Liofilchem s.r.l. | 510(k) | Jan 11, 2019FDA decision date |
| Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Omadacycline in the dilution range of 0.03-32ug/mlK183033 · JWY | Thermo Fisher Scientific | 510(k) | Jan 4, 2019FDA decision date |
| MTS Levofloxacin 0.002 - 32 µg/mLK183115 · JWY | Liofilchem s.r.l. | 510(k) | Dec 20, 2018FDA decision date |
| MTS Omadacycline 0.002-32 µg/mLK182922 · JWY | Liofilchem s.r.l. | 510(k) | Dec 14, 2018FDA decision date |
| Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Eravacycline in the dilution range of 0.008- 16 µg/mLK182797 · JWY | Thermo Fisher Scientific | 510(k) | Nov 30, 2018FDA decision date |
| MTS Eravacycline 0.002 - 32 µg/mLK182557 · JWY | Liofilchem s.r.l. | 510(k) | Nov 2, 2018FDA decision date |
| BECKMAN COULTER MicroScan MICroSTREP Plus Panel, MicroScan Mueller-Hinton Broth with 3% lysed horse blood, Catalog Number 81015 MicroScan Muelle…Z-1804-2018 · JWY | Beckman Coulter Inc. | Recall | Oct 2, 2018FDA classification date |
| MTS Penicillin 0.002- 32 µg/mLK181889 · JWY | Liofilchem s.r.l. | 510(k) | Sep 13, 2018FDA decision date |
| Sensititre 18-24 hour MIC Breakpoint Susceptibility System with Plazomicin in the dilution range of 0.06-128 ug/mLK181946 · JWY | Thermo Fisher Scientific | 510(k) | Aug 8, 2018FDA decision date |
| MTS Plazomicin 0.016-256 µg/mLK181708 · JWY | Liofilchem s.r.l. | 510(k) | Jul 31, 2018FDA decision date |
| ETEST Telavancin (TLA) (0.002-32 ug/mL)K180936 · JWY | Biomerieux S.A. | 510(k) | Jul 3, 2018FDA decision date |
| Liofilchem MIC Test Strip (MTS), Delafloxacin 0.002 - 32 ug/mLK180886 · JWY | Liofilchem s.r.l. | 510(k) | May 18, 2018FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.